Better survival seen in NSCLC patients who take beta blockers

01/15/2013 | News-Medical.Net

A new study has found beta blocker treatment was associated with better survival without distant metastases, improved disease-free survival and better overall survival among patients with non-small-cell lung cancer being treated with definitive radiotherapy compared with those who did not take beta blockers. The research appears in the Annals of Oncology.

View Full Article in:

News-Medical.Net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID